Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise C Hsu

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Current Topics in Microbiology and Immunology|October 27, 2017
Immune Interventions to Eliminate the HIV ReservoirDenise C Hsu, Jintanat Ananworanich
Drugs|February 26, 2016
Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV InfectionDenise C Hsu, Irini Sereti
Journal of the International AIDS Society|February 16, 2019
Longitudinal changes in HIV DNA in HIV controllers: what do they mean?Denise C Hsu, John W Mellors
The Medical Journal of Australia|November 6, 2007
Is "nut-free" sunflower seed butter safe for children with peanut allergy?Denise C Hsu, Constance H Katelaris
Human Vaccines & Immunotherapeutics|March 11, 2017
Progress in HIV vaccine developmentDenise C Hsu, Robert J O'Connell
AIDS Research and Therapy|December 17, 2013
Serious Non-AIDS events: Immunopathogenesis and interventional strategiesDenise C Hsu, Irini Sereti, Jintanat Ananworanich
Frontiers in Immunology|July 29, 2021
Can Broadly Neutralizing HIV-1 Antibodies Help Achieve an ART-Free Remission?Denise C Hsu, John W Mellors, Sandhya Vasan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2015
A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRISDenise C Hsu, Kimberly F Faldetta, Luxin Pei, et al.
AIDS (London, England)|October 22, 2019
Plasma tissue factor and immune activation are associated with carotid intima-media thickness progression in treated HIV infectionDenise C Hsu, Yi Fei Ma, Amrit Narwan, et al.
AIDS (London, England)|May 14, 2016
Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapyDenise C Hsu, Yi Fei Ma, Sophia Hur, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Topics in Microbiology and Immunology|October 27, 2017
Immune Interventions to Eliminate the HIV ReservoirDenise C Hsu, Jintanat Ananworanich
Drugs|February 26, 2016
Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV InfectionDenise C Hsu, Irini Sereti
Journal of the International AIDS Society|February 16, 2019
Longitudinal changes in HIV DNA in HIV controllers: what do they mean?Denise C Hsu, John W Mellors
The Medical Journal of Australia|November 6, 2007
Is "nut-free" sunflower seed butter safe for children with peanut allergy?Denise C Hsu, Constance H Katelaris
Human Vaccines & Immunotherapeutics|March 11, 2017
Progress in HIV vaccine developmentDenise C Hsu, Robert J O'Connell
AIDS Research and Therapy|December 17, 2013
Serious Non-AIDS events: Immunopathogenesis and interventional strategiesDenise C Hsu, Irini Sereti, Jintanat Ananworanich
Frontiers in Immunology|July 29, 2021
Can Broadly Neutralizing HIV-1 Antibodies Help Achieve an ART-Free Remission?Denise C Hsu, John W Mellors, Sandhya Vasan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2015
A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRISDenise C Hsu, Kimberly F Faldetta, Luxin Pei, et al.
AIDS (London, England)|October 22, 2019
Plasma tissue factor and immune activation are associated with carotid intima-media thickness progression in treated HIV infectionDenise C Hsu, Yi Fei Ma, Amrit Narwan, et al.
AIDS (London, England)|May 14, 2016
Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapyDenise C Hsu, Yi Fei Ma, Sophia Hur, et al.
Pageof 4